- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00015574
Air Pollution and Implantable Cardioverter Defibrillators
Study Overview
Status
Conditions
Detailed Description
Records of cardiac arrhythmias detected in patients with implanted cardioverter defibrillators will be linked with measurements of the concentration and constituents of ambient particulate air pollution. Time series methods will be used to assess temporal associations, adjusting for seasonal, weekly, and diurnal patterns, meteorology, and co-pollutants. Characteristics of subjects showing the strongest air pollution associations will be assessed, as well as effect modification by medication and co-morbidities.
ICD patients are followed up clinically every three to six months. The ICD device is interrogated and data are retrieved by non-invasive radio frequency retrieval from the implanted device. Device performance is checked. Detected arrhythmias and therapeutic interventions are listed. For each detected episode, date and time is recorded, along with a short electrogram of the heartbeats immediately before and during the event.
Daily ambient particle mass (PM10 and PM2.5) and particle constituents have been measured in Boston since January 1995. The Massachusetts Department of Environmental Protection has measured concentrations of gaseous pollutants including carbon monoxide, nitrogen dioxide, ozone, and sulfur dioxide. Meteorological factors including temperature, humidity, and barometric pressure have been measured at the National Weather Service station at Logan airport. Meteorologic factors and gaseous co-pollutants will be considered as independent predictors of arrhythmic events, and as confounders of the particulate air pollution associations.
Study Type
Enrollment
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- New England Medical Center, Cardiac Arrhythmia Service
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Study Plan
How is the study designed?
Design Details
Collaborators and Investigators
Collaborators
Investigators
- Study Director: Douglas Dockery, ScD, Harvard School of Public Health (HSPH)
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Completion
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9825-CP-002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arrythmias
-
Abbott Medical DevicesCompletedHeart Failure | Ventricular ArrythmiasUnited States
-
F. Mueller-RiemenschneiderBiotronik SE & Co. KGUnknownVentricular ArrythmiasGermany
-
Trillium Health CentreUnknownVentricular ArrythmiasCanada
-
Population Health Research InstituteCompleted
-
Boston Scientific CorporationRecruitingCardiac ArrythmiasUnited States, Monaco, Italy
-
University of British ColumbiaCompletedCardiac ArrythmiasCanada
-
Barts & The London NHS TrustLondon School of Hygiene and Tropical MedicineCompleted
-
MicroPort CRMSorin Group France SASTerminated
-
NYU Langone HealthSuspended
-
CardiacSense Ltd.Completed